Current Progress of Phytomedicine in Glioblastoma Therapy

Abstract

Glioblastoma multiforme, an intrusive brain cancer, has the lowest survival rate of all brain cancers. The chemotherapy utilized to prevent their proliferation and propagation is limited due to modulation of complex cancer signalling pathways. These complex pathways provide infiltrative and drug evading properties leading to the development of chemotherapy resistance. Therefore, the development and discovery of such interventions or therapies that can bypass all these resistive barriers to ameliorate glioma prognosis and survival is of profound importance. Medicinal plants are comprised of an exorbitant range of phytochemicals that have the broad-spectrum capability to target intrusive brain cancers, modulate anti-cancer pathways and immunological responses to facilitate their eradication, and induce apoptosis. These phytocompounds also interfere with several oncogenic proteins that promote cancer invasiveness and metastasis, chemotherapy resistance and angiogenesis. These plants are extremely vital for promising anti-glioma therapy to avert glioma proliferation and recurrence. In this review, we acquired recent literature on medicinal plants whose extracts/bioactive ingredients are newly exploited in glioma therapeutics, and also highlighted their mode of action and pharmacological profile.

Keywords

phytomedicine / phytochemicals / glioblastoma / chemotherapy resistance / bioactive

References

[1] AlifierisC, TrafalisDT. Glioblastoma multiforme: Pathogenesis and treatment. Pharmacol Ther, 2015, 152: 63-82

[2] CrespoI, VitalAL, Gonzalez-TablasM, et al.. Molecular and Genomic Alterations in Glioblastoma Multiforme. Am J Pathol, 2015, 185(7): 1820-1833

[3] HanifF, MuzaffarK, PerveenK, et al.. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment. Asian Pac J Cancer Prev, 2017, 18(1): 3-9

[4] AnjumK, ShaguftaBI, AbbasSQ, et al.. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review. Biomed Pharmacother, 2017, 92: 681-689

[5] StavrovskayaAA, ShushanovSS, RybalkinaEY. Problems of glioblastoma multiforme drug resistance. Biochem, 2016, 81(2): 91-100

[6] LeeSY. Temozolomide resistance in glioblastoma multiforme. Genes Dis, 2016, 3(3): 198-210

[7] NagelZD, KitangeGJ, GuptaSK, et al.. DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme. Cancer Res, 2017, 77(1): 198-206

[8] MaW, LiN, AnY, et al.. Effects of Temozolomide and Radiotherapy on Brain Metastatic Tumor: A Systematic Review and Meta-Analysis. World Neurosurg, 2016, 92: 197-205

[9] GreenwellM, RahmanPKSM. Medicinal Plants: Their Use in Anticancer Treatment. Int J Pharm Sci Res, 2015, 6(10): 4103-4112

[10] ShuklaS, MehtaA. Anticancer potential of medicinal plants and their phytochemicals: a review. Brazilian J Bot, 2015, 38(2): 199-210

[11] SalehiB, ZuccaP, Sharifi-RadM, et al.. Phytotherapeutics in cancer invasion and metastasis. Phyther Res, 2018, 32(8): 1425-1449

[12] ChenW, WangD, DuX, et al.. Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes. Med Oncol, 2015, 32(3): 43

[13] CalinescuAA, CastroMG. Microtubule targeting agents in glioma. Transl Cancer Res, 2016, 5(Suppl 1): S54-60

[14] OsukaS, Van MeirE. Overcoming therapeutic resistance in glioblastoma: the way forward. J Clin Invest, 2017, 127(2): 415-426

[15] MukhtarE, AdhamiVM, MukhtarH. Targeting microtubules by natural agents for cancer therapy. Mol Cancer Ther, 2014, 13(2): 275-284

[16] HashemiM, GharaylouZ, SepandMR, et al.. Apoptosis Induced by Viola odorata Extract in Human Glioblastoma Multiforme. Arch Neurosci, 2019, 6(1): e81233

[17] OrdysBB, LaunayS, DeightonRF, et al.. The role of mitochondria in glioma pathophysiology. Mol Neurobiol, 2010, 42(1): 64-75

[18] ChaudhuriD, GhateNB, SinghSS, et al.. Methyl gallate isolated from Spondias pinnata exhibits anticancer activity against human glioblastoma by induction of apoptosis and sustained extracellular signal-regulated kinase 1/2 activation. Pharmacogn Mag, 2015, 11(42): 269-276

[19] LuY, JiangF, JiangH, et al.. Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells. Eur J Pharmacol, 2010, 641(2–3): 102-107

[20] ZhengX, JiangF, KatakowskiM, et al.. ADAM17 promotes glioma cell malignant phenotype. Mol Carcinog, 2012, 51(2): 150-164

[21] HanL, YangY, YueX, et al.. Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription. Brain Res, 2010, 1366: 9-17

[22] Zhou YX, Xin HL, Rahman K, et al. Portulaca oleracea L.: a review of phytochemistry and pharmacological effects. Biomed Res Int, 2015:925631

[23] YanJ, SunLR, ZhouZY, et al.. Homoisoflavonoids from the medicinal plant Portulaca oleracea. Phytochemistry, 2012, 80: 37-41

[24] RahimiVB, MousaviSH, HaghighiS, et al.. Cytotoxicity and apoptogenic properties of the standardized extract of Portulaca oleracea on glioblastoma multiforme cancer cell line (U-87): a mechanistic study. EXCLI J, 2019, 18: 165-186

[25] AskariVR, RezaeeSA, AbnousK, et al.. The influence of hydro-ethanolic extract of Portulaca oleracea L. on Th1/Th2 balance in isolated human lymphocytes. J Ethnopharmacol, 2016, 194: 1112-1121

[26] JeongJC, KimMS, KimTH, et al.. Kaempferol Induces Cell Death Through ERK and Akt-Dependent Down-Regulation of XIAP and Survivin in Human Glioma Cells. Neurochem Res, 2009, 34(5): 991-1001

[27] StumpTA, SanteeBN, WilliamsLP, et al.. The antiproliferative and apoptotic effects of apigenin on glioblastoma cells. J Pharm Pharmacol, 2017, 69(7): 907-916

[28] ParkSE, SapkotaK, KimS, et al.. Kaempferol acts through mitogen-activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells. Br J Pharmacol, 2011, 164(3): 1008-1025

[29] SharmaV, JosephC, GhoshS, et al.. Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther, 2007, 6(9): 2544-2553

[30] TranAN, BoydNH, WalkerK, et al.. NOS Expression and NO Function in Glioma and Implications for Patient Therapies. Antioxid Redox Signal, 2017, 26(17): 986-999

[31] PreethiK, EllanghiyilS, KuttanG, et al.. Induction of apoptosis of tumor cells by some potentiated homeopathic drugs: implications on mechanism of action. Integr Cancer Ther, 2012, 11(2): 172-182

[32] PushpaH, RamyaN, ShibaniP, et al.. Screening of Antimicrobial, Antioxidant and Anticancer Activity of Ruta graveolens. Adv Biol Res, 2015, 9(4): 257-264

[33] FadlallaK, WatsonA, YehualaeshetT, et al.. Ruta graveolens extract induces DNA damage pathways and blocks Akt activation to inhibit cancer cell proliferation and survival. Anticancer Res, 2011, 31(1): 233-241

[34] GentileMT, CinigliaC, RecciaMG, et al.. Ruta graveolens L. Induces Death of Glioblastoma Cells and Neural Progenitors, but Not of Neurons, via ERK 1/2 and AKT Activation. PLoS One, 2015, 10(3): e0118864

[35] BaldéES, MegalizziV, TraoréMS, et al.. In vitro antiprotozoal, antimicrobial and antitumor activity of Pavetta crassipes K. Schum leaf extracts. J Ethnopharmacol, 2010, 130(3): 529-535

[36] BelloIA, NdukweGI, AuduOT, et al.. A bioactive flavonoid from Pavetta crassipes K. Schum. Org Med Chem Lett, 2011, 1(1): 14

[37] WilcoxRM, HusemanE, LinS, et al.. Evaluation of the Anticancer Activity of Bioactive Fraction G Extracted from Pavetta crassipes in Malignant Brain Tumor Cell Lines. Am J Phytomedicine Clin Ther, 2017, 5(2): 16

[38] BukkeAN, HadiFN, BabuKS, et al.. In vitro. Data Br, 2018, 19: 868-877

[39] KimSH, LyuHN, KimYS, et al.. Brazilin Isolated From Caesalpinia Sappan Suppresses Nuclear Envelope Reassembly by Inhibiting Barrier-To-Autointegration Factor Phosphorylation. J Pharmacol Exp Ther, 2015, 352(1): 175-184

[40] LeeDY, LeeMK, KimGS, et al.. Brazilin inhibits growth and induces apoptosis in human glioblastoma cells. Molecules, 2013, 18(2): 2449-2457

[41] KhanRS, SenthiM, RaoPC, et al.. Cytotoxic constituents of Abutilon indicum leaves against U87MG human glioblastoma cells. Nat Prod Res, 2015, 29(11): 1069-1073

[42] KueteV, DzotamJK, VoukengIK, et al.. Cytotoxicity of methanol extracts of Annona muricata, Passiflora edulis and nine other Cameroonian medicinal plants towards multi-factorial drug-resistant cancer cell lines. Springerplus, 2016, 5(1): 1666

[43] ReisRM, SilvaVAO, RosaMN, et al.. Cytotoxic effect of euphol from Euphorbia tirucalli on a large panel of human cancer cell lines. J Clin Oncol, 2013, 31(15_suppl): e13557-e13557

[44] SilvaVAO, RosaMN, Miranda-GonçalvesV, et al.. Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells. Invest New Drugs, 2019, 37(2): 223-237

[45] QuassintiL, MaggiF, OrtolaniF, et al.. Exploring new applications of tulip tree (Liriodendron tulipifera L.): leaf essential oil as apoptotic agent for human glioblastoma. Environ Sci Pollut Res, 2019, 26(29): 30485-30497

[46] GaglianoN, MoscheniC, TorriC, et al.. Effect of Ukrain on matrix metalloproteinase-2 and Secreted Protein Acidic and Rich in Cysteine (SPARC) expression in human glioblastoma cells. Anticancer Drugs, 2006, 17(2): 189-194

[47] GaglianoN, MoscheniC, TorriC, et al.. Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells. Anticancer Drugs, 2007, 18(6): 669-676

[48] Lee YK, Lee KW, Kim M, et al. Chelidonine Induces Caspase-Dependent and Caspase-Independent Cell Death through G2/M Arrest in the T98G Human Glioblastoma Cell Line. Evidence-Based Complement Altern Med, 2019:6318179

[49] SuY, BamoduOA, TzengYM, et al.. Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide. Phytomedicine, 2019, 61: 152840

[50] Boik J. Natural compounds in cancer therapy. Oregon Medical Press Princeton, MN 2001.

[51] AuffingerB, SpencerD, PytelP, et al.. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence. Expert Rev Neurother, 2015, 15(7): 741-752

[52] KesarwaniK, GuptaR, MukerjeeA. Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed, 2013, 3(4): 253-266

[53] PugliaC, LauroMR, TirendiGG, et al.. Modern drug delivery strategies applied to natural active compounds. Expert Opin Drug Deliv, 2017, 14(6): 755-768

[54] Subramanian K, Sankaramourthy D, Gunasekaran M. In: Mandal SC, Mandal V, Konishi TBT-NP and DD, eds. Chapter 18 — Toxicity Studies Related to Medicinal Plants. Elsevier, 2018:491–505

[55] NeklesaTK, WinklerJD, CrewsCM. Targeted protein degradation by PROTACs. Pharmacol Ther, 2017, 174: 138-144

[56] CaesarLK, CechNB. Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2. Nat Prod Rep, 2019, 36(6): 869-888

[57] VengojiR, MachaMA, BatraSK, et al.. Natural products: a hope for glioblastoma patients. Oncotarget, 2018, 9(31): 22194-22219

[58] TrogrlićI, TrogrlićD, TrogrlićD, et al.. Treatment of glioblastoma with herbal medicines. World J Surg Oncol, 2018, 16(1): 28